Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tax inversion
Pharma
Takeda pays €130M to settle AbbVie-Shire breakup fee
After years spent challenging a tax break fee tethered to its massive Shire buyout, Takeda has settled with Irish authorities.
Fraiser Kansteiner
Oct 18, 2023 11:30am
Takeda's Shire buyout yields tax setback in Ireland
Aug 2, 2021 10:59am
AbbVie, Shire investors settle lawsuit over scuttled merger
Apr 12, 2019 11:50am
Mylan CEO's EpiPen defense reverberates in pricing debate
Jun 4, 2018 11:06am
Mylan cut its tax rate deeply with coal investments: Reuters
Jun 21, 2017 10:06am
Brace yourself, pharma: Tax inversions could return
Apr 24, 2017 11:22am
